onc Videos

Videos

Elizabeth Brem University of California Irvine

Videos

Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL

04/20/2023

In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.

In a debate at the 2023 Great...

04/20/2023

Oncology

Joseph Herman, MD, Northwell Health Cancer Institute

Videos

The Role of Radiation Therapy for Borderline Resectable Pancreas Cancer

04/20/2023

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Joseph Herman, MD, discussed the argument against use of radiotherapy in borderline resectable pancreas cancer.

At the 2023 Great Debates and...

04/20/2023

Oncology

Videos

An Argument Against Radiation Therapy for Borderline Resectable Pancreas Cancer

04/20/2023

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Lisa Kachnic, MD, discussed the argument against use of radiotherapy in borderline resectable pancreas cancer.

At the 2023 Great Debates and...

04/20/2023

Oncology

Anup Kasi, MD, University of Kansas Cancer Center

Videos

Adjuvant Immunotherapy for Upper GI Tract Cancers

04/20/2023

Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.

Anup Kasi, MD, discusses the...

04/20/2023

Oncology

Videos

Diagnostics and Risk Stratification for Patients With Polycythemia Vera

04/19/2023

Claire Harrison, MD, discusses the latest updates in diagnostics and risk stratification of polycythemia vera with Jean-Jacques Kiladjian, MD, and Alessandro Rambaldi, MD.

Claire Harrison, MD, discusses...

04/19/2023

Oncology

Jennifer Amengual, MD, Columbia University

Videos

Choosing Treatment Options for Patients With R/R DLBCL Ineligible for CAR T-Cell Therapy

04/18/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies in New York, New York, Jennifer Amengual, MD, discussed the process of choosing among non-CAR-T options for patients with recurrent aggressive lymphoma, particularly DLBCL.

At the 2023 Great Debates &...

04/18/2023

Oncology

Basil Njei, MD, MPH, PhD, Yale University

Videos

Is There a Role For Artificial Intelligence in Cholangiocarcinoma Diagnosis?

04/18/2023

Basil Njei, MD, MPH, PhD, discusses his research into the use of artificial intelligence in the detection of malignant biliary strictures and cholangiocarcinoma.

Basil Njei, MD, MPH, PhD,...

04/18/2023

Oncology

Videos

Circulating Tumor DNA and Prediction of Early Progression in Follicular Lymphoma

04/13/2023

Margarita Sánchez-Beato, PhD, discusses the monitoring of circulating tumor DNA to predict response to treatment and early progression among patients with follicular lymphoma.

Margarita Sánchez-Beato, PhD,...

04/13/2023

Oncology

Arvind Dasari, MD, MD Anderson Cancer Center

Videos

Key Considerations When Treating Patients With NETs

04/13/2023

Arvind Dasari, MD, discusses the important points clinicians should consider when treating patients with neuroendocrine tumors.

Arvind Dasari, MD, discusses the...

04/13/2023

Oncology

Videos

New and Upcoming Options for Neuroendocrine Tumors

04/13/2023

Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.

Arvind Dasari, MD, reviews the...

04/13/2023

Oncology

Recent News

News

Pembrolizumab Plus Gemcitabine-Platinum Doublet Chemotherapy Improves Survival Regardless of Platinum Agent for Urothelial Carcinoma

11/19/2024

Stephanie Holland ;

Subset analysis results from the phase 3 KEYNOTE-361 study demonstrated that the addition of pembrolizumab to gemcitabine-platinum doublet chemotherapy improved survival for patients with advanced or metastatic urothelial carcinoma,...

Subset analysis results from the...

11/19/2024

Oncology

News

Addition of Toripalimab to First-Line Chemotherapy Improves Survival for Patients With Extensive-Stage Small Cell Lung Cancer

11/19/2024

Stephanie Holland ;

Results from the phase 3 EXTENTORCH trial demonstrated that the addition of toripalimab to first-line chemotherapy significantly improved survival among patients with extensive-stage small cell lung cancer.

Results from the phase 3...

11/19/2024

Oncology

News

Adjuvant Chemotherapy Followed by Radiation May Benefit Patients With High-Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a phase 2 trial, adjuvant docetaxel-cisplatin followed by radiation therapy may benefit patients with high-risk endometrial cancer.

According to a phase 2 trial,...

11/19/2024

Oncology

News

Robotic Laparoscopy May Have Easier Recovery For Patients With Early-Stage, Low Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a randomized clinical trial, there may be benefits to inflammation processes, tissue damage, stress and recovery time with robotic laparoscopy for early-stage endometrial cancer compared to conventional laparoscopy.

According to a randomized...

11/19/2024

Oncology

News

UGN-102 Chemoablation as TURBT Alternative for Patients With Recurrent Low-Grade Non-Muscle Invasive Bladder Cancer

11/19/2024

Stephanie Holland ;

According to results from the phase 3 ENVISION trial, chemoablation with UGN-102 demonstrates clinical promise as an alternative to standard-of-care transurethral resection of the bladder tumor for patients with recurrent low-grade...

According to results from the...

11/19/2024

Oncology

News

Tumor Mutational Status May Predict Recurrence, Survival Patterns for Patients With Early-Stage Non-Small Cell Lung Cancer

11/18/2024

Stephanie Holland ;

According to results from a retrospective analysis, tumor mutational status can potentially predict recurrence and survival patterns for patients with surgically resected, stage I non-small cell lung cancer.

According to results from a...

11/18/2024

Oncology

News

FDA Grants Approval to Revumenib for Patients With R/R Acute Leukemia With KMT2A Translocation

11/17/2024

On November 15, 2024, the FDA approved menin inhibitor revumenib for adult and pediatric patients 1 year and older with relapsed/refractory acute leukemia with KMT2A translocation.

On November 15, 2024, the FDA...

11/17/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology